DNMT3A and neoplasm: Subsequently, low DNMT3A expression decreases methylation levels in HAVCR2 and LGALS9 promoters, promoting Tim-3 and Galectin-9 expression in HeLa and C-33A CC cells [125], suppressing the anti-tumor immunity mediated by innate and adaptive immune cells [126].